Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1992 2
1993 2
1994 1
1995 2
1996 3
1997 6
1998 2
1999 4
2000 2
2001 5
2002 2
2003 5
2004 3
2005 8
2006 4
2007 3
2008 4
2009 2
2010 1
2011 6
2012 5
2013 6
2014 5
2015 3
2016 5
2017 6
2018 2
2019 1
2020 8
2021 5
2022 5
2023 0
Text availability
Article attribute
Article type
Publication date

Search Results

112 results
Results by year
Filters applied: . Clear all
Page 1
Autologous hematopoietic stem cell transplantation vs intravenous pulse cyclophosphamide in diffuse cutaneous systemic sclerosis: a randomized clinical trial.
van Laar JM, Farge D, Sont JK, Naraghi K, Marjanovic Z, Larghero J, Schuerwegh AJ, Marijt EW, Vonk MC, Schattenberg AV, Matucci-Cerinic M, Voskuyl AE, van de Loosdrecht AA, Daikeler T, Kötter I, Schmalzing M, Martin T, Lioure B, Weiner SM, Kreuter A, Deligny C, Durand JM, Emery P, Machold KP, Sarrot-Reynauld F, Warnatz K, Adoue DF, Constans J, Tony HP, Del Papa N, Fassas A, Himsel A, Launay D, Lo Monaco A, Philippe P, Quéré I, Rich É, Westhovens R, Griffiths B, Saccardi R, van den Hoogen FH, Fibbe WE, Socié G, Gratwohl A, Tyndall A; EBMT/EULAR Scleroderma Study Group. van Laar JM, et al. Among authors: sont jk. JAMA. 2014 Jun 25;311(24):2490-8. doi: 10.1001/jama.2014.6368. JAMA. 2014. PMID: 25058083 Free article. Clinical Trial.
Blueprint for harmonising unstandardised disease registries to allow federated data analysis: prepare for the future.
Kroes JA, Bansal AT, Berret E, Christian N, Kremer A, Alloni A, Gabetta M, Marshall C, Wagers S, Djukanovic R, Porsbjerg C, Hamerlijnck D, Fulton O, Ten Brinke A, Bel EH, Sont JK. Kroes JA, et al. Among authors: sont jk. ERJ Open Res. 2022 Oct 4;8(4):00168-2022. doi: 10.1183/23120541.00168-2022. eCollection 2022 Oct. ERJ Open Res. 2022. PMID: 36199590 Free PMC article. Review.
Telemanagement in asthma: an innovative and effective approach.
Van Gaalen JL, Hashimoto S, Sont JK. Van Gaalen JL, et al. Among authors: sont jk. Curr Opin Allergy Clin Immunol. 2012 Jun;12(3):235-40. doi: 10.1097/ACI.0b013e3283533700. Curr Opin Allergy Clin Immunol. 2012. PMID: 22475997 Review.
Real-World Effectiveness of Reslizumab in Patients With Severe Eosinophilic Asthma - First Initiators and Switchers.
Hashimoto S, Kroes JA, Eger KA, Mau Asam PF, Hofstee HB, Bendien SA, Braunstahl GJ, Broeders MEAC, Imming LM, Langeveld B, Maitland-van der Zee AH, Oud KTM, Patberg KW, Smeenk FWJM, Romme EAPM, van Bezouw MJ, van de Ven MJ, van Veen A, van Velzen E, van Veen IHPAA, Weersink EJM, Ten Brinke A, Sont JK, Bel EH; RAPSODI team. Hashimoto S, et al. Among authors: sont jk. J Allergy Clin Immunol Pract. 2022 Aug;10(8):2099-2108.e6. doi: 10.1016/j.jaip.2022.04.014. Epub 2022 Apr 26. J Allergy Clin Immunol Pract. 2022. PMID: 35487369 Free article.
Treatment Eligibility of Real-Life Mepolizumab-Treated Severe Asthma Patients.
Richards LB, van Bragt JJMH, Aarab R, Longo C, Neerincx AH, Sont JK, Weersink EJM, Braunstahl GJ, Brinke AT, Bel EHD, Maitland-van der Zee AH. Richards LB, et al. Among authors: sont jk. J Allergy Clin Immunol Pract. 2020 Oct;8(9):2999-3008.e1. doi: 10.1016/j.jaip.2020.04.029. Epub 2020 Apr 25. J Allergy Clin Immunol Pract. 2020. PMID: 32344189
112 results